India's drug price regulator has capped retail prices for 53 drug formulations used in treating various diseases and conditions to ensure these medicines are affordable to the common public.

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Several domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly ...

New Delhi: India’s drug price regulator has capped the retail prices of 53 formulations or ... NPPA has fixed the retail price at ₹14.98 per tablet for a combination drug (acetylcysteine ...

With the expiry of patents for several essential medicines, the prices of key drugs, including those for diabetes, asthma, ...

The best cheap tablets aren't as powerful as the best tablets, but they do offer bright screens, great battery life, and bag-friendly portability. In this guide, we've highlighted the best cheap ...

Last year, sales of tablet devices to consumers grew to 2.6 million units—up 24% since 2023, as per data shared with Mint by market researcher International Data Corporation (IDC) India.